MS
Paramount Skydance Gets a Double Upgrade. It’s the Warner Bros. Deal.
Paramount Skydance shares are moving higher on Friday after receiving a bullish double upgrade from Morgan Stanley.
Barrons.com  ·  May 01, 2026 READ →
BTCUSDT
Galaxy Says Jack Mallers’ XXI Could Rival MicroStrategy After Tether’s Proposed Merger
Galaxy Research says Tether's plan to merge XXI with Strike and Elektron could create MicroStrategy's closest Bitcoin rival.
BeInCrypto  ·  May 01, 2026 READ →
USDTUSD
Galaxy Says Jack Mallers’ XXI Could Rival MicroStrategy After Tether’s Proposed Merger
Galaxy Research says Tether's plan to merge XXI with Strike and Elektron could create MicroStrategy's closest Bitcoin rival.
BeInCrypto  ·  May 01, 2026 READ →
JPM
Aluminum Gains as Trump Vows to Maintain Naval Blockade on Iran
(Bloomberg) -- Aluminum gained, with traders seeing little prospect of an imminent opening of the Strait of Hormuz that would ease availability of the metal.Most Read from BloombergUS Seeks to Deploy Hypersonic Missile for the First Time Against IranTwo NJ Malls Separated by Just Four Miles — and Very Different FatesTrump Family-Backed Drone Firm Signs Weapons Deal With USTrump Says Iran Blockade ‘Incredible’ as Pump Prices Keep RisingNorth Korea Confirms Suicide Rule for Soldiers Ukraine Captur
Bloomberg  ·  May 01, 2026 READ →
NVDA
Income Investors Can Rely on Ford’s Dividend: Here’s Why the Payout Is Secure
Ford (NYSE: F) sells trucks, SUVs, and commercial vehicles, with Ford Pro and Ford Blue carrying the profit load while Model e bleeds cash. Shares trade near $12, and management just declared another $0.15 quarterly dividend. With an $8.2 billion net loss in 2025 on the books, the key question is whether this dividend payout ... Income Investors Can Rely on Ford’s Dividend: Here’s Why the Payout Is Secure
24/7 Wall St.  ·  May 01, 2026 READ →
MRK
Merck Expands Beyond Oncology With New HIV RSV Allergy And Rare Disease Bets
Merck (NYSE:MRK) is expanding in allergy and rare disease markets, including chlorpheniramine maleate and pancreatic neuroendocrine tumor treatments. The company received FDA approval for IDVYNSO, a new two drug HIV regimen supported by late stage trial data. The European Commission approved ENFLONSIA (clesrovimab) for RSV prevention in infants, adding another pediatric-focused therapy to Merck's portfolio. For you as an investor, these developments show how Merck is adding new therapeutic...
Simply Wall St.  ·  May 01, 2026 READ →
INTC
Century Aluminum Is Building a $4 Billion Smelter. Is CENX Stock a Buy Right Now?
The largest producer of primary aluminum in the United States is partnering with Emirates Global Aluminum to build the first new aluminum smelter in the U.S. in 46 years.
Motley Fool  ·  May 01, 2026 READ →
NVDA
Century Aluminum Is Building a $4 Billion Smelter. Is CENX Stock a Buy Right Now?
The largest producer of primary aluminum in the United States is partnering with Emirates Global Aluminum to build the first new aluminum smelter in the U.S. in 46 years.
Motley Fool  ·  May 01, 2026 READ →
CRM
Salesforce Changes Financial Disclosure On AI Products. Good Or Bad For Investors?
Salesforce stock climbed after the software maker said it will disclose more granular data about revenue from AI products in quarterly earnings.
Investor's Business Daily  ·  May 01, 2026 READ →
SYK
Stryker maintains FY26 outlook despite cyberattack-impacted Q1
Stryker was hit by a cyberattack that caused widespread disruption to its operations on 11 March 2026.
Medical Device Network  ·  May 01, 2026 READ →
GOOGL
'Big Consensus Trade' — Billionaire Stanley Druckenmiller Is Betting On This Metal Amid Tight Supply and Surging Demand From AI Data Centers
Copper is a no-brainer investment due to rising demand from AI data centers and tight supply, according to billionaire investor Stanley Druckenmiller. In an interview with Morgan Stanley in February, Druckenmiller said his Duquesne Family Office holds copper as its...
Benzinga  ·  May 01, 2026 READ →
AMZN
'Big Consensus Trade' — Billionaire Stanley Druckenmiller Is Betting On This Metal Amid Tight Supply and Surging Demand From AI Data Centers
Copper is a no-brainer investment due to rising demand from AI data centers and tight supply, according to billionaire investor Stanley Druckenmiller. In an interview with Morgan Stanley in February, Druckenmiller said his Duquesne Family Office holds copper as its...
Benzinga  ·  May 01, 2026 READ →